PATENT CLAIM ANALYSIS

Application Number: 15781328
Application Type: Utility
Filing Date: 2018-06
Publication Date: 2019-02
Patent Classification: ["424", "204100"]

Abstract:
Disclosed are a mutated HPV11 L1 protein (or a variant thereof), a sequence encoding the same, a method for preparing the same, and a virus-like particle comprising the same, wherein the protein (or a variant thereof) and the virus-like particle can induce the generation of neutralizing antibodies against at least two HPV types (e.g. HPV11 and HPV6), and therefore can be used to prevent infection by said at least two HPV types, and a disease caused by said infection, such as cervical cancer and condyloma acuminatum. Also disclosed is use of the protein and the virus-like particle in the manufacture of a pharmaceutical composition or a vaccine for preventing infection by said at least two HPV types, and a disease caused by said infection, such as cervical cancer and condyloma acuminatum.

Claim (Index 16):
The pharmaceutical composition or vaccine according to  claim 7 , wherein the HPV virus-like particle is present in an amount effective for preventing HPV infection or a disease caused by HPV infection.

Metadata:
- Claim Count in Document: 47.0
- Percentile: 94.0
- Lexical Diversity: 2.25758
- Patent Class: 424.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: True
- Related Applications: ['12601972', '15924511', '15350264', '12601983', '12598187']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7942162344715752
- 35 USC 102 Novelty (BERT): 0.5547528587433798
- Combined Prediction Score: 0.7702698968987556
- Mean Citation Score: 421.34043600000007
- Max Citation Score: 433.55557000000016
- Similarity Product: 341.96491122433554

Labels:
- Claim Label 101: 1
- Claim Label 102: 0
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 0
- Label 101 Adjusted: 1

Dataset: test